View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 11, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Herbalife Ltd: 1 director

A director at Herbalife Ltd bought 15,000 shares at 10.548USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Journey Medical Corporation to Announce First Quarter 2024 Financial R...

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30 p.m. ET SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its first quarter...

 PRESS RELEASE

Lee Enterprises to Present at Sidoti Virtual Investor Conference

Lee Enterprises to Present at Sidoti Virtual Investor Conference DAVENPORT, Iowa, May 06, 2024 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ: LEE) today announced its Chief Executive Officer, Kevin Mowbray, and Chief Financial Officer, Tim Millage, will hold a group presentation and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference, taking place on May 8-9, 2024. The group presentation will begin at 2:30pm ET on May 8, 2024, and can be accessed live . Lee Enterprises will also host virtual one-on-one with investors on Wednesday and Thursday...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 4, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Lee Enterprises reports second quarter Adjusted EBITDA growth and stro...

Lee Enterprises reports second quarter Adjusted EBITDA growth and strong digital growth Adjusted EBITDA(1) growth of 5% YOYDigital-only subscription revenue increased 48%(2) with subscriptions up 25%Total Digital Revenue(3) of $71M represented 48% of total revenue DAVENPORT, Iowa, May 02, 2024 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ: LEE), a digital-first subscription platform providing high quality, trusted, local news, information and a major platform for advertising in 73 markets, today reported preliminary second quarter fiscal 2024 financial results(4) for the peri...

 PRESS RELEASE

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial...

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer SCOTTSDALE, Ariz., May 01, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the appointment of Joseph M. Benesch as Chief Financial Officer, effective April 26, 2024. Mr. Benesch had served as the Company’s Int...

 PRESS RELEASE

Lee Enterprises adds Chief Transformation and Commercial Officer

Lee Enterprises adds Chief Transformation and Commercial Officer DAVENPORT, Iowa, May 01, 2024 (GLOBE NEWSWIRE) -- Les Ottolenghi, a Fortune 500 senior technology and cybersecurity executive, has joined Lee Enterprises, Incorporated (NASDAQ:LEE), as Chief Transformation and Commercial Officer. Kevin Mowbray, Lee’s President and Chief Executive Officer, said the senior-level role was created to advance and accelerate Lee’s industry-leading digital growth and further strengthen market supremacy. “Les brings over 25 years of leadership experience in large public corporations an...

 PRESS RELEASE

Journey Medical Corporation to Present at the Planet MicroCap Showcase...

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024 SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, announced today that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap...

 PRESS RELEASE

Lee Enterprises plans quarterly call and webcast May 2, 2024

Lee Enterprises plans quarterly call and webcast May 2, 2024 DAVENPORT, Iowa, April 22, 2024 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ: LEE), a major subscription and advertising platform and a leading provider of high quality, trusted, local news and information in 73 markets, has scheduled an audio webcast and conference call for Thursday, May 2, 2024, at 9 a.m. Central Time. Lee plans to issue a news release before the market opens that day with preliminary results for its second quarter ended March 24, 2024. A live webcast of the conference call may be accessed via...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: April 20, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 18, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: April 15, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch